Cancer remains one of the most harmful diseases worldwide as the American Cancer Society estimates that 1.6 million new cases of cancer are diagnosed each year and over 35% will result in death. The practice of oncology continually faces the challenge of matching the right therapeutic regimen with the right patient. This challenge is often daunting with only marginal success rates. As a result, new understanding of the biology of cancer is essential to develop better therapeutics and the ability to translate basic science discoveries into the clinical setting.
The Mission of the Duke Scholars in Oncology and Cellular Therapies (DSOC) Program is to provide training for pre-doctoral and post-doctoral scientists interested in cancer research and to promote opportunities for scientists to interact with physicians to gain experience and an understanding of the clinical problems in oncology.
What are the key program components?
The Duke Oncology Scholars in Molecular Medicine Program features several key components to facilitate a greater understanding and appreciation for translational medicine and clinical questions.
-
Direct interaction with clinicians and clinical scientists during patient care encounters across a wide range of adult and pediatric oncology subspecialties. Leading Duke Cancer Institute oncologists recognized for their teaching proficiency and mentoring were selected to form monthly rotations in the DCI in medical oncology and radiation oncology.
-
Attend a national oncology meeting (American Society of Clinical Oncology (ASCO) or American Society of Hematology (ASH)) to network with national oncology experts and colleagues.
-
Attend specialty tumor boards and clinical conferences across the DCI and at a national level.
-
End of year presentation at Hematology-Oncology Grand Rounds to foster collaboration between scholars and members of the Duke Cancer Institute.
Who should apply?
Candidates should be in a pre-doctoral program or are currently in a post-doctoral position and have interest in cancer biology.
For more Information, contact:
Andrew Armstrong
David Hsu
Stephanie Sarantopoulos
Mentors in Oncology and Cellular Therapies
Dr. Gwynn Long
Adult Stem Cell Therapy
Dr. Stefanie Sarantopoulos
Adult Stem Cell Therapy
Dr. Kelly Marcom
Breast Oncology
Dr. Jim Abbruzzese
GI Oncology
Dr. Gerry Blobe
GI Oncology
Dr. John Strickler
GI Oncology
Dr. Andrew Armstrong
GU Oncology
Dr. Carlos DeCastro
Leukemia
Dr. Harry Erba
Leukemia
Dr. Ahmed Galal
Lymphoma
Dr. Danielle Brander
Lymphoma
Dr. Brent Hanks
Melanoma
Dr. April Salama
Melanoma
Dr. Rich Riedel
Sarcoma
Dr. Will Eward
Sarcoma
Dr. Shannon McCall
Surgical Pathology
Dr. Jeff Crawford
Thoracic Oncology
Dr. Neal Ready
Thoracic Oncology
Dr. Jeff Clarke
Thoracic Oncology
Departments & Divisions
Department of Radiation Oncology
Division of Hematological Malignancies and Cellular Therapy | Department of Medicine
Division of Medical Oncology | Department of Medicine
Division of Surgical Oncology | Department of Surgery